Company intelligence / Profile preview

Blotting Innovations

Central, South Carolina, United Statesblottinginnovations.com ↗

Ownership: Private
Development stage: Commercial

Overview

Blotting Innovations has developed the G-BLOT, a 96-well high-throughput Western blot system that increases throughput up to eightfold compared to traditional gels. The product integrates with standard lab reagents and equipment, making precise and efficient protein analysis more accessible for researchers in academic and clinical labs. The company has received grant funding to support commercialization efforts.

Modalities: Protein analysis toolsWestern blot technology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Blotting Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blotting Innovations.

Explore the full profile